NCCN 指南解读：结肠癌，第 2.2018 版。
NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
出版信息
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.
Abstract
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.
摘要
NCCN 结肠癌指南提供了关于诊断、病理分期、手术管理、围手术期治疗、监测、复发性和转移性疾病的管理以及生存的建议。这些 NCCN 指南洞察总结了 NCCN 结肠癌专家组在 2018 年更新指南时关于 III 期结肠癌患者的风险分层和辅助治疗以及含有维莫非尼的方案治疗 V600E 突变阳性转移性结直肠癌的讨论。
相似文献
1
NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.
2
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw. 2013 May 1;11(5):519-28. doi: 10.6004/jnccn.2013.0069.
3
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152. doi: 10.6004/jnccn.2013.0022.
4
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2021 Mar 2;19(3):329-359. doi: 10.6004/jnccn.2021.0012.
5
NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.
J Natl Compr Canc Netw. 2020 Jul;18(7):806-815. doi: 10.6004/jnccn.2020.0032.
6
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2017 Mar;15(3):370-398. doi: 10.6004/jnccn.2017.0036.
7
Rectal Cancer, Version 2.2015.
J Natl Compr Canc Netw. 2015 Jun;13(6):719-28; quiz 728. doi: 10.6004/jnccn.2015.0087.
8
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.
Clin Colorectal Cancer. 2011 Jun;10(2):113-6. doi: 10.1016/j.clcc.2011.03.007. Epub 2011 Apr 22.
9
Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer.
Cancer. 2013 Apr 15;119(8):1593-601. doi: 10.1002/cncr.27935. Epub 2012 Dec 21.
10
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw. 2024 Apr;22(3):140-150. doi: 10.6004/jnccn.2024.0019.
引用本文的文献
1
Research progress on predicting KRAS gene mutations in colorectal cancer by combining radiomics and multimodal medical imaging.
Front Oncol. 2025 Aug 20;15:1605915. doi: 10.3389/fonc.2025.1605915. eCollection 2025.
2
Automatic labels are as effective as manual labels in digital pathology images classification with deep learning.
J Pathol Inform. 2025 Jul 22;18:100462. doi: 10.1016/j.jpi.2025.100462. eCollection 2025 Aug.
3
Radiomics-based prediction of microsatellite instability in colorectal cancer: a non-invasive approach to treatment stratification.
Radiol Med. 2025 Sep 2. doi: 10.1007/s11547-025-02081-0.
4
Spatial Domain-Based Approach to Analyze the Mechanism of Sparganii Rhizoma-Curcumae Rhizoma Pair in the Treatment of Colorectal Cancer.
Food Sci Nutr. 2025 Aug 19;13(8):e70794. doi: 10.1002/fsn3.70794. eCollection 2025 Aug.
5
Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy.
Clin Transl Oncol. 2025 Aug 21. doi: 10.1007/s12094-025-04029-2.
6
Most eligible candidates for primary tumor resection among metastatic colorectal cancer patients: a SEER-based population analysis.
Transl Cancer Res. 2025 Jul 30;14(7):4381-4398. doi: 10.21037/tcr-2025-1084. Epub 2025 Jul 24.
7
A Study to Evaluate the Potential Role and Clinical Application Value of Long Noncoding RNA CASC Family Members in Colorectal Cancer Based on Transcriptomic Data.
Int J Genomics. 2025 Jul 24;2025:3881424. doi: 10.1155/ijog/3881424. eCollection 2025.
8
Current status and advances in the treatment of colorectal cancer with liver metastases.
World J Clin Oncol. 2025 Jul 24;16(7):107438. doi: 10.5306/wjco.v16.i7.107438.
9
Silent Yet Striking: Medullary Carcinoma Behind an Intestinal Obstruction.
Cureus. 2025 Jun 24;17(6):e86669. doi: 10.7759/cureus.86669. eCollection 2025 Jun.
10
Log odds of positive lymph nodes-based staging system for colorectal cancer patients with inadequate lymph nodes harvested: a potential reference for adjuvant chemotherapy.
J Gastrointest Oncol. 2025 Jun 30;16(3):1038-1049. doi: 10.21037/jgo-2024-910. Epub 2025 Jun 16.
本文引用的文献
1
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).
J Clin Oncol. 2021 Feb 1;39(4):285-294. doi: 10.1200/JCO.20.01994. Epub 2020 Dec 23.
2
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
J Clin Oncol. 2018 Mar 10;36(8):773-779. doi: 10.1200/JCO.2017.76.9901. Epub 2018 Jan 20.
3
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
Colorectal cancer statistics, 2017.
CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.
5
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.
Cancer Discov. 2016 Dec;6(12):1352-1365. doi: 10.1158/2159-8290.CD-16-0050. Epub 2016 Oct 11.
6
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.
JAMA Oncol. 2017 Feb 1;3(2):194-201. doi: 10.1001/jamaoncol.2016.3797.
7
Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Cancer. 2016 Nov 15;122(21):3277-3287. doi: 10.1002/cncr.30181. Epub 2016 Jul 15.
8
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
Oncologist. 2016 Aug;21(8):988-94. doi: 10.1634/theoncologist.2016-0084. Epub 2016 Jul 5.
9
Cancer statistics, 2016.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
10
Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
J Natl Compr Canc Netw. 2016 Jan;14(1):47-56. doi: 10.6004/jnccn.2016.0006. Epub 2016 Jan 5.
Zotero 插件